Ribometrix Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Ribometrix is a platform therapeutics company that discovers small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.

Repeat Founder
Company Highlights
Year Founded

2014

icon-altEmployees

29

Location (HQ)

USA

Since Last Funding

5 years 1 month

Monthly Website Visitors

1.8K

icon-altTotal Investment Amt

$45M

Last Funding Round

Series Unknown

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Health Care

Biotechnology Research

Life Science

Pharmaceutical